Future Trouble in Macro? Liquidity Traps and a Slowing Global Credit Impulse
The Interview: Could a slowdown in credit creation and a tightening of monetary conditions push bond yields lower and threaten risk assets? Alfonso Peccatiello, fixed income investor and publisher of ...
25 Heinä 20211h 6min
Raoul Pal & Julian Brigden: Diving into the Macro
DB-Jul23,2021: Along with Real Vision senior editor Ash Bennington, Real Vision CEO and co-founder Raoul Pal welcomes Julian Brigden, co-founder of MI2 Partners, for his Real Vision Daily Briefing deb...
24 Heinä 202144min
Jobless Claims Rise -- What This Means for Central Bank Tapering
DB-Jul22,2021: Petr Pinkhasov of Real Vision's Exchange joins Real Vision’s Samuel Burke and Jack Farley on the Daily Briefing to discuss new data related to jobless claims in addition to developments...
22 Heinä 202135min
The Ongoing Evolution of the Ethereum Network
Crypto Special ; Real Vision senior editor Ash Bennington welcomes Ryan Berckmans, investor and Ethereum community member, to discuss the evolution of Ethereum and the changes forthcoming that will fu...
22 Heinä 202155min
Is the Sell-Off Over? Making Sense of a Market in Flux
DB-Jul21,2021: Peter Boockvar, CIO of Bleakley Advisory Group, joins Real Vision’s Ash Bennington and Jack Farley on the Daily Briefing to share his insights into market expectations of economic growt...
22 Heinä 202137min
Tony Greer's Market Update: Inflation, Equities, Bonds, and More
DB-Jul20,2021: With U.S. stocks rallying off of yesterday’s steep selloff while bonds remain relatively flat, what risks are markets pricing in currently, and what opportunities does that lead to for ...
21 Heinä 202136min
Global Equity Markets Recoil as Delta Variant Concerns Rise
DB-Jul19,2021: Darius Dale, founder of 42 Macro, joins Real Vision’s Jack Farley and Ash Bennington to share his updated framework on equity markets, bond yields, and oil prices as delta variant conce...
20 Heinä 202135min
Christian Angermayer: Investing in the Therapeutic Potential for Psychedelics
The Interview: Christian Angermayer, founder of Apeiron Investments, Atai Life Sciences, and COMPASS Pathways, made headlines for attributing his decision to invest in Bitcoin to a trip on mushrooms, ...
19 Heinä 20211h 8min
